Form
| Dosage
| Status
| Therapeutic Equivalence
| Active Ingred
| Ref.
| Sponsor
| Document
|
CAPSULE, DELAYED RELEASE; ORAL
| 27,600USP UNITS;13,800USP UNITS;27,600USP UNITS
| Prescription
|
| PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
| Pancrelipase
| APTALIS PHARMA US
| 22222
2012-03-15 Medication Guide 2012-03-01 Label 2012-03-01 Letter |
CAPSULE, DELAYED RELEASE; ORAL
| 41,400USP UNITS;20,700USP UNITS;41,400USP UNITS
| Prescription
|
| PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
| Pancrelipase
| APTALIS PHARMA US
| " |
CAPSULE, DELAYED RELEASE; ORAL
| 46,000USP UNITS;23,000USP UNITS;46,000USP UNITS
| Prescription
| (Reference Drug)
| PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
| Pancrelipase
| APTALIS PHARMA US
| " |